SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Orchid Pharma - Quaterly Results

26 May 2025 Evaluate
The revenue for the March 2025 quarter is pegged at Rs. 2374.79 millions, about 9.39% up against Rs. 2171.02 millions recorded during the year-ago period.A slender decline of -16.08% was recorded to Rs. 278.50  millions from Rs. 331.87 millions in the corresponding previous quarter.The company reported a degrowth in operating Profit to 405.92 millions from 418.10 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 2374.79 2171.02 9.39 9219.26 8193.68 12.52 9219.26 8193.68 12.52
Other Income 62.57 128.85 -51.44 319.29 303.89 5.07 319.29 303.89 5.07
PBIDT 405.92 418.10 -2.91 1554.60 1410.70 10.20 1554.60 1410.70 10.20
Interest 39.80 34.47 15.46 145.40 163.28 -10.95 145.40 163.28 -10.95
PBDT 366.12 383.63 -4.56 1409.20 1247.42 12.97 1409.20 1247.42 12.97
Depreciation 87.62 84.02 4.28 344.36 332.19 3.66 344.36 332.19 3.66
PBT 278.50 299.61 -7.05 1064.84 915.23 16.35 1064.84 915.23 16.35
TAX 0.00 -32.26 0.00 0.00 -32.26 0.00 0.00 -32.26 0.00
Deferred Tax 0.00 -32.26 0.00 0.00 -32.26 0.00 0.00 -32.26 0.00
PAT 278.50 331.87 -16.08 1064.84 947.49 12.39 1064.84 947.49 12.39
Equity 507.19 507.19 0.00 507.19 507.19 0.00 507.19 507.19 0.00
PBIDTM(%) 17.09 19.26 -11.24 16.86 17.22 -2.06 16.86 17.22 -2.06

Orchid Pharma Share Price

544.95 -14.25 (-2.55%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×